HealthLynked (HLYK) Long-Term Investments (2021 - 2022)
HealthLynked (HLYK) posted quarterly Long-Term Investments of $300600.0 for Q4 2022, down 79.34% year-over-year from $1.5 million in Q4 2021, and up 17.88% quarter-over-quarter from $255000.0 in Q3 2022.
Powered by 
Analysis
HealthLynked (HLYK) Long-Term Investments (2021 - 2022) Analysis & Trends
HealthLynked (HLYK) has reported Long-Term Investments for 2 consecutive years, with $300600.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Long-Term Investments fell 79.34% year-over-year to $300600.0; the TTM figure through Dec 2022 stood at $300600.0 (down 79.34% YoY), while the FY2022 annual figure was $300600.0, down 79.34% from the prior year.
- Long-Term Investments advanced to $300600.0 in Q4 2022 per HLYK's latest filing, from $255000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $1.5 million in Q4 2021 and bottomed at $165000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 813.00 Mn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 3.80 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 183.80 Mn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | - |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | - |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 148.15 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | HealthLynked | 7.44 Mn | 7.43 Mn | 127,645.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 300,600.00 |
| Sep 30, 2022 | 255,000.00 |
| Jun 30, 2022 | 165,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | 1.45 Mn |